Drug class in one race
D2/D3 drugs for Parkinson's Disease
2 tracked D2/D3 drugs in the Parkinson's Disease race. The class explanation lives on the D2/D3 page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
1 Phase 31 Phase 2
Head-to-head evidence: Matsupexole (KDT-3594) vs Piribedil (Clarium)